ENALAPRIL MALEATE ORAL SOLUTION
Generic: ENALAPRIL MALEATE
NorthStar RxLLCManufacturer
ORALRoute
ENALAPRIL MALEATEActive Substance
2022-02-24Original Approval
ENALAPRIL MALEATE ORAL SOLUTION is FDA application ANDA214467, sponsored by ANNORA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DIARRHOEA
993 reports
2
NAUSEA
986 reports
3
DYSPNOEA
957 reports
4
FATIGUE
848 reports
5
DIZZINESS
809 reports
6
DRUG INTERACTION
793 reports
7
DRUG INEFFECTIVE
727 reports
8
VOMITING
714 reports
9
ASTHENIA
658 reports
10
PAIN
646 reports